These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 30120774)

  • 1. Getting to Long-Term Effectiveness and Safety of Attention-deficit Hyperactivity Disorder Medications.
    Beau-Lejdstrom R; Zito JM
    Clin Pharmacol Ther; 2018 Oct; 104(4):610-612. PubMed ID: 30120774
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Jury Is Still Out on the Benefits and Harms of Methylphenidate for Children and Adolescents With Attention-Deficit/Hyperactivity Disorder.
    Storebø OJ; Faltinsen E; Zwi M; Simonsen E; Gluud C
    Clin Pharmacol Ther; 2018 Oct; 104(4):606-609. PubMed ID: 30006934
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Using ADHD Medications to Treat Coexisting ADHD and Reading Disorders: A Systematic Review.
    Froehlich TE; Fogler J; Barbaresi WJ; Elsayed NA; Evans SW; Chan E
    Clin Pharmacol Ther; 2018 Oct; 104(4):619-637. PubMed ID: 30053315
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treating a Child With Mental Illness.
    Ito S
    Clin Pharmacol Ther; 2018 Oct; 104(4):592-594. PubMed ID: 30222188
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early life exposure to air pollution particulate matter (PM) as risk factor for attention deficit/hyperactivity disorder (ADHD): Need for novel strategies for mechanisms and causalities.
    Myhre O; Låg M; Villanger GD; Oftedal B; Øvrevik J; Holme JA; Aase H; Paulsen RE; Bal-Price A; Dirven H
    Toxicol Appl Pharmacol; 2018 Sep; 354():196-214. PubMed ID: 29550511
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MR imaging of the effects of methylphenidate on brain structure and function in attention-deficit/hyperactivity disorder.
    Schweren LJ; de Zeeuw P; Durston S
    Eur Neuropsychopharmacol; 2013 Oct; 23(10):1151-64. PubMed ID: 23165220
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of comorbid autism spectrum disorders on stimulant response in children with attention deficit hyperactivity disorder: a retrospective and prospective effectiveness study.
    Santosh PJ; Baird G; Pityaratstian N; Tavare E; Gringras P
    Child Care Health Dev; 2006 Sep; 32(5):575-83. PubMed ID: 16919137
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The use of melatonin in Swedish children and adolescents--a register-based study according to age, gender, and medication of ADHD.
    Furster C; Hallerbäck MU
    Eur J Clin Pharmacol; 2015 Jul; 71(7):877-81. PubMed ID: 25995170
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trends in attention-deficit hyperactivity disorder medication use: a retrospective observational study using population-based databases.
    Raman SR; Man KKC; Bahmanyar S; Berard A; Bilder S; Boukhris T; Bushnell G; Crystal S; Furu K; KaoYang YH; Karlstad Ø; Kieler H; Kubota K; Lai EC; Martikainen JE; Maura G; Moore N; Montero D; Nakamura H; Neumann A; Pate V; Pottegård A; Pratt NL; Roughead EE; Macias Saint-Gerons D; Stürmer T; Su CC; Zoega H; Sturkenbroom MCJM; Chan EW; Coghill D; Ip P; Wong ICK
    Lancet Psychiatry; 2018 Oct; 5(10):824-835. PubMed ID: 30220514
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Medications used in the treatment of disruptive behavior in children with FASD--a guide.
    Ozsarfati J; Koren G
    J Popul Ther Clin Pharmacol; 2015; 22(1):e59-67. PubMed ID: 25715382
    [TBL] [Abstract][Full Text] [Related]  

  • 11. European, randomized, phase 3 study of lisdexamfetamine dimesylate in children and adolescents with attention-deficit/hyperactivity disorder.
    Coghill D; Banaschewski T; Lecendreux M; Soutullo C; Johnson M; Zuddas A; Anderson C; Civil R; Higgins N; Lyne A; Squires L
    Eur Neuropsychopharmacol; 2013 Oct; 23(10):1208-18. PubMed ID: 23332456
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnosis and treatment of attention-deficit/hyperactivity disorder in children and adolescents. Council on Scientific Affairs, American Medical Association.
    Goldman LS; Genel M; Bezman RJ; Slanetz PJ
    JAMA; 1998 Apr; 279(14):1100-7. PubMed ID: 9546570
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Developing a Risk Score to Guide Individualized Treatment Selection in Attention Deficit/Hyperactivity Disorder.
    Setyawan J; Yang H; Cheng D; Cai X; Signorovitch J; Xie J; Erder MH
    Value Health; 2015 Sep; 18(6):824-31. PubMed ID: 26409610
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exposure to Surgery and Anesthesia in Early Childhood and Subsequent Use of Attention Deficit Hyperactivity Disorder Medications.
    Ing C; Ma X; Sun M; Lu Y; Wall MM; Olfson M; Li G
    Anesth Analg; 2020 Sep; 131(3):723-733. PubMed ID: 31923004
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trends in ADHD medication use in children and adolescents in five western countries, 2005-2012.
    Bachmann CJ; Wijlaars LP; Kalverdijk LJ; Burcu M; Glaeske G; Schuiling-Veninga CCM; Hoffmann F; Aagaard L; Zito JM
    Eur Neuropsychopharmacol; 2017 May; 27(5):484-493. PubMed ID: 28336088
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ADHD Drug Prescribing Trend Is Increasing Among Children and Adolescents in Hong Kong.
    Man KKC; Ip P; Hsia Y; Chan EW; Chui CSL; Lam MPS; Wong WHS; Chow CB; Yung A; Wong ICK
    J Atten Disord; 2017 Dec; 21(14):1161-1168. PubMed ID: 24994875
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Attention-deficit-hyperactivity disorder: an update.
    Dopheide JA; Pliszka SR
    Pharmacotherapy; 2009 Jun; 29(6):656-79. PubMed ID: 19476419
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of attention-deficit/hyperactivity disorder.
    Jadad AR; Boyle M; Cunningham C; Kim M; Schachar R
    Evid Rep Technol Assess (Summ); 1999 Nov; (11):i-viii, 1-341. PubMed ID: 10790990
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Time Trends in the Frequencies of ADHD and Stimulant Medication].
    Steinhausen HC; Döpfner M; Schubert I
    Z Kinder Jugendpsychiatr Psychother; 2016; 44(4):275-84. PubMed ID: 27434688
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Physician perceptions of the use of medications for attention deficit hyperactivity disorder.
    Stockl KM; Hughes TE; Jarrar MA; Secnik K; Perwien AR
    J Manag Care Pharm; 2003; 9(5):416-23. PubMed ID: 14613439
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.